A decade ago.experts were predicting further integration of contract research organizations (CROs) in clinical trials.And for the most part.they were right.What 21 December 2017
In light of a recent case, David Prange and Christopher Pinahs, from USA-based law firm Robins Kaplan, provide an Expert View piece containing potentially cruci 19 December 2017
In an Expert View piece, Rosanne Kay, partner at international law firm Reed Smith, considers when to escalate matters to an internal investigation, and how bes 14 December 2017
Last week.the UK government published its latest annual update on its five year strategy to combat antimicrobial resistance (AMR).AMR.widely accepted as one of 7 December 2017
The global life sciences and pharmaceuticals sector is undergoing a wave of strategic M&A activity, as incumbents make acquisitions to enhance the technological 4 December 2017
Charlie Johnson, chief executive of antibody drug conjugate (ADC) specialist ADC Bio, considers some of the challenges and solutions involved with developing AD 29 November 2017
Aside from issues concerning how to enforce second medical patents.the validity issues at the core of the Warner-Lambert case are on their way to the UK Supreme 23 November 2017
In an area like oncology.innovation is needed not just with the end product.but in the way that researchers get there.finds Rik Van Mol.vice president of R&D st 15 November 2017
In an Expert View piece, Ulrike Gottwald-Hostalek, senior medical director at Merck KGaA, and Kerstin Brand, director of global medical affairs for diabetes at 10 November 2017
In light of the progress and potential of cell and gene therapies.Amy Grogg.senior vice president of strategy and communication at US drug wholesale company Ame 7 November 2017
An expert view piece by Steven Shill, Patrick Pilch and David Friend from the BDO Center for Healthcare Excellence & Innovation, on what drug manufacturers shou 31 October 2017
Steven Powell, chief executive of UK-based immuno-oncology (I-O) company Macrophage Pharma, gives an overview of developments in this fast-moving space in an Ex 25 October 2017
A cloud continues to loom over the implementation of the Unified Patent Convention, a system permitting a single patent covering numerous European countries, wr 11 October 2017
In an Expert View piece, Balkrishan ‘BK’ Kalra, life sciences business leader and Eric Sandor, PVAI business leader, from technology and analytics specialist Ge 3 October 2017
The fast-changing and pressurized environment in which they operate means pharma companies must now take a more aggressive approach to adopting new leadership s 28 September 2017
Bid defenses have traditionally been considered the gold standard for culminating the contract research organization (CRO) selection process.writes Laurie Hallo 21 September 2017
In his second Expert View piece, Yungjoon Kwon, patent/trademark attorney and managing director at law firm Kwon & Kim, considers a South Korean court’s view on 14 September 2017
Mark Engelman, head of intellectual property at UK-based law firm Hardwicke, offers his interpretation on a landmark ruling in an Expert View piece. 5 September 2017
Changes affecting the patentability of precision medicines could open the door to more research activity and lead to the discovery of new targeted treatments th 31 August 2017
After hearing a pharma view in our previous Expert View column, a legal perspective is provided by Nick Beckett, global co-head of lifesciences at law firm CMS. 22 August 2017
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.